Bank of New York Mellon’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $473M | Sell |
758,492
-6,919
| -0.9% | -$4.71M | 0.08% | 225 |
|
|
2026
Q1 | $591M | Buy |
765,411
+1,169
| +0.2% | +$895K | 0.11% | 179 |
|
|
2025
Q4 | $590M | Buy |
764,242
+92,612
| +14% | +$62.9M | 0.1% | 172 |
|
|
2025
Q3 | $378M | Buy |
671,630
+15,006
| +2% | +$8.48M | 0.07% | 244 |
|
|
2025
Q2 | $345M | Sell |
656,624
-41,629
| -6% | -$23.2M | 0.07% | 259 |
|
|
2025
Q1 | $443M | Buy |
698,253
+8,990
| +1% | +$6.18M | 0.09% | 212 |
|
|
2024
Q4 | $491M | Sell |
689,263
-25,813
| -4% | -$21.7M | 0.09% | 202 |
|
|
2024
Q3 | $752M | Sell |
715,076
-149,166
| -17% | -$166M | 0.14% | 138 |
|
|
2024
Q2 | $908M | Sell |
864,242
-22,302
| -3% | -$21.6M | 0.17% | 109 |
|
|
2024
Q1 | $853M | Sell |
886,544
-62,031
| -7% | -$59M | 0.16% | 117 |
|
|
2023
Q4 | $833M | Sell |
948,575
-18,839
| -2% | -$15.5M | 0.17% | 121 |
|
|
2023
Q3 | $796M | Buy |
967,414
+2,666
| +0.3% | +$2.1M | 0.18% | 116 |
|
|
2023
Q2 | $693M | Sell |
964,748
-29,220
| -3% | -$22.5M | 0.15% | 132 |
|
|
2023
Q1 | $817M | Buy |
993,968
+9,496
| +1% | +$7.16M | 0.18% | 121 |
|
|
2022
Q4 | $710M | Sell |
984,472
-38,252
| -4% | -$28.2M | 0.16% | 127 |
|
|
2022
Q3 | $705M | Buy |
1,022,724
+64,867
| +7% | +$40.8M | 0.17% | 117 |
|
|
2022
Q2 | $566M | Buy |
957,857
+40,799
| +4% | +$26.5M | 0.13% | 154 |
|
|
2022
Q1 | $640M | Buy |
917,058
+33,036
| +4% | +$20.9M | 0.12% | 153 |
|
|
2021
Q4 | $558M | Buy |
884,022
+3,207
| +0.4% | +$1.97M | 0.1% | 180 |
|
|
2021
Q3 | $533M | Buy |
880,815
+22,199
| +3% | +$13.8M | 0.1% | 174 |
|
|
2021
Q2 | $480M | Buy |
858,616
+12,578
| +1% | +$6.37M | 0.09% | 195 |
|
|
2021
Q1 | $400M | Buy |
846,038
+17,774
| +2% | +$8.65M | 0.08% | 214 |
|
|
2020
Q4 | $400M | Buy |
828,264
+8,138
| +1% | +$4.39M | 0.09% | 189 |
|
|
2020
Q3 | $459M | Buy |
820,126
+46,975
| +6% | +$28.5M | 0.11% | 159 |
|
|
2020
Q2 | $482M | Buy |
773,151
+160,589
| +26% | +$91.2M | 0.13% | 147 |
|
|
2020
Q1 | $299M | Buy |
612,562
+11,889
| +2% | +$4.9M | 0.1% | 183 |
|
|
2019
Q4 | $226M | Sell |
600,673
-101
| -0% | -$34K | 0.06% | 300 |
|
|
2019
Q3 | $167M | Sell |
600,774
-2,032
| -0.3% | -$601K | 0.05% | 358 |
|
|
2019
Q2 | $189M | Sell |
602,806
-2,576
| -0.4% | -$858K | 0.05% | 342 |
|
|
2019
Q1 | $249M | Buy |
605,382
+13,539
| +2% | +$5.58M | 0.07% | 264 |
|
|
2018
Q4 | $221M | Sell |
591,843
-13,101
| -2% | -$4.8M | 0.07% | 262 |
|
|
2018
Q3 | $244M | Buy |
604,944
+7,520
| +1% | +$2.86M | 0.06% | 294 |
|
|
2018
Q2 | $206M | Buy |
597,424
+1,055
| +0.2% | +$330K | 0.06% | 333 |
|
|
2018
Q1 | $205M | Sell |
596,369
-22,041
| -4% | -$7.67M | 0.06% | 335 |
|
|
2017
Q4 | $232M | Sell |
618,410
-26,608
| -4% | -$10.8M | 0.06% | 328 |
|
|
2017
Q3 | $288M | Sell |
645,018
-124,768
| -16% | -$59.4M | 0.08% | 261 |
|
|
2017
Q2 | $378M | Sell |
769,786
-112,081
| -13% | -$49M | 0.11% | 203 |
|
|
2017
Q1 | $342M | Buy |
881,867
+237,157
| +37% | +$87.9M | 0.09% | 220 |
|
|
2016
Q4 | $237M | Buy |
644,710
+1,249
| +0.2% | +$475K | 0.07% | 300 |
|
|
2016
Q3 | $259M | Sell |
643,461
-8,507
| -1% | -$3.41M | 0.08% | 276 |
|
|
2016
Q2 | $228M | Sell |
651,968
-19,679
| -3% | -$7.58M | 0.07% | 292 |
|
|
2016
Q1 | $242M | Sell |
671,647
-141,489
| -17% | -$58.3M | 0.07% | 276 |
|
|
2015
Q4 | $441M | Sell |
813,136
-91,702
| -10% | -$49.7M | 0.13% | 161 |
|
|
2015
Q3 | $421M | Sell |
904,838
-30,002
| -3% | -$16.1M | 0.13% | 158 |
|
|
2015
Q2 | $477M | Sell |
934,840
-496
| -0.1% | -$242K | 0.13% | 157 |
|
|
2015
Q1 | $423M | Sell |
935,336
-9,774
| -1% | -$4.14M | 0.11% | 203 |
|
|
2014
Q4 | $388M | Buy |
945,110
+2,405
| +0.3% | +$946K | 0.1% | 213 |
|
|
2014
Q3 | $340M | Sell |
942,705
-44,945
| -5% | -$15.1M | 0.09% | 231 |
|
|
2014
Q2 | $279M | Sell |
987,650
-25,618
| -3% | -$7.59M | 0.08% | 281 |
|
|
2014
Q1 | $304M | Sell |
1,013,268
-189,651
| -16% | -$58.4M | 0.08% | 255 |
|
|
2013
Q4 | $331M | Sell |
1,202,919
-38,489
| -3% | -$11.1M | 0.09% | 223 |
|
|
2013
Q3 | $388M | Buy |
1,241,408
+162,887
| +15% | +$42.8M | 0.12% | 180 |
|
|
2013
Q2 | $243M | Buy |
+1,078,521
| New | +$251M | 0.08% | 263 |
|
Other funds holding REGN
Bank of New York Mellon's REGN Position: Q2 2026 in Review
Bank of New York Mellon reduced its Regeneron Pharmaceuticals (REGN) stake by 0.9% in Q2 2026, selling an estimated $4.71M and leaving 758,492 shares worth $473M. The position accounts for 0.08% of the portfolio, ranked #225.
Bank of New York Mellon first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $908M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Bank of New York Mellon held 758,492 shares of Regeneron Pharmaceuticals worth $473M as of Q2 2026.
- Bank of New York Mellon sold 6,919 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.71M.
- Regeneron Pharmaceuticals made up 0.08% of Bank of New York Mellon's portfolio in Q2 2026, its #225 holding.
- Bank of New York Mellon first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Regeneron Pharmaceuticals position peaked at $908M in Q2 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.